486 related articles for article (PubMed ID: 16038768)
21. Histopathological studies of visceralized Leishmania (Leishmania) amazonensis in mice experimentally infected.
Abreu-Silva AL; Calabrese KS; Cupolilo SM; Cardoso FO; Souza CS; Gonçalves da Costa SC
Vet Parasitol; 2004 May; 121(3-4):179-87. PubMed ID: 15135858
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of anti-leishmanial activity by induction of nitric oxide and inhibition of prostaglandin in Balb/c mice infected with Leishmania major.
Nahrevanian H; Hajihosseini R; Arjmand M; Farahmand M; Ghasemi F
Southeast Asian J Trop Med Public Health; 2009 Nov; 40(6):1188-98. PubMed ID: 20578452
[TBL] [Abstract][Full Text] [Related]
23. Leishmania amazonensis: xylitol as inhibitor of macrophage infection and stimulator of macrophage nitric oxide production.
Ferreira AS; de Souza MA; Barbosa NR; da Silva SS
Exp Parasitol; 2008 May; 119(1):74-9. PubMed ID: 18316079
[TBL] [Abstract][Full Text] [Related]
24. Canova medication modifies parasitological parameters in mice infected with Trypanosoma cruzi.
Pupulin AR; Marques-Araujo S; Toledo MJ; Gomes ML; Takejima E; Cuman RK; Bersani-Amado CA
Exp Parasitol; 2010 Dec; 126(4):435-40. PubMed ID: 20433834
[TBL] [Abstract][Full Text] [Related]
25. Lack of signaling by IL-4 or by IL-4/IL-13 has more attenuating effects on Leishmania amazonensis dorsal skin--than on footpad-infected mice.
Felizardo TC; Gaspar-Elsas MI; Lima GM; Abrahamsohn IA
Exp Parasitol; 2012 Jan; 130(1):48-57. PubMed ID: 22019418
[TBL] [Abstract][Full Text] [Related]
26. Effect of HIV protease inhibitors on New World Leishmania.
Demarchi IG; Silveira TG; Ferreira IC; Lonardoni MV
Parasitol Int; 2012 Dec; 61(4):538-44. PubMed ID: 22579524
[TBL] [Abstract][Full Text] [Related]
27. Liposomal-lupane system as alternative chemotherapy against cutaneous leishmaniasis: macrophage as target cell.
Barros NB; Migliaccio V; Facundo VA; Ciancaglini P; Stábeli RG; Nicolete R; Silva-Jardim I
Exp Parasitol; 2013 Oct; 135(2):337-43. PubMed ID: 23933281
[TBL] [Abstract][Full Text] [Related]
28. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.
Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA
Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166
[TBL] [Abstract][Full Text] [Related]
29. Effect of imidocarb and levamisole on the experimental infection of BALB/c mice by Leishmania (Leishmania) amazonensis.
Rodrigues FH; Afonso-Cardoso SR; Gomes MA; Beletti ME; Rocha A; Guimarães AH; Candeloro I; de Souza MA
Vet Parasitol; 2006 Jun; 139(1-3):37-46. PubMed ID: 16647821
[TBL] [Abstract][Full Text] [Related]
30. Activity of physalins purified from Physalis angulata in in vitro and in vivo models of cutaneous leishmaniasis.
Guimarães ET; Lima MS; Santos LA; Ribeiro IM; Tomassini TB; Ribeiro dos Santos R; dos Santos WL; Soares MB
J Antimicrob Chemother; 2009 Jul; 64(1):84-7. PubMed ID: 19454526
[TBL] [Abstract][Full Text] [Related]
31. The histopathological and immunological pattern of CBA mice infected with Leishmania amazonensis after treatment with pyrazole carbohydrazide derivatives.
Charret KS; Lagrota-Cândido J; Carvalho-Pinto CE; Hottz CF; Lira ML; Rodrigues RF; Gomes AO; Bernardino AM; Canto-Cavalheiro MM; Leon LL; Amaral VF
Exp Parasitol; 2013 Feb; 133(2):201-10. PubMed ID: 23219949
[TBL] [Abstract][Full Text] [Related]
32. Aryl thiosemicarbazones: In vitro and immunomodulatory activities against L. amazonensis.
da Silva AC; Dos Santos TAR; da Silva IVB; de Oliveira MVG; Moreira DRM; Leite ACL; Pereira VRA
Exp Parasitol; 2017 Jun; 177():57-65. PubMed ID: 28433563
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory activity of limonene against Leishmania parasites in vitro and in vivo.
Arruda DC; Miguel DC; Yokoyama-Yasunaka JK; Katzin AM; Uliana SR
Biomed Pharmacother; 2009 Nov; 63(9):643-9. PubMed ID: 19321295
[TBL] [Abstract][Full Text] [Related]
34. Role of interleukin-4 and prostaglandin E2 in Leishmania amazonensis infection of BALB/c mice.
Guimarães ET; Santos LA; Ribeiro dos Santos R; Teixeira MM; dos Santos WL; Soares MB
Microbes Infect; 2006 Apr; 8(5):1219-26. PubMed ID: 16531090
[TBL] [Abstract][Full Text] [Related]
35. Influence of long-term treatment with pravastatin on the survival, evolution of cutaneous lesion and weight of animals infected by Leishmania amazonensis.
Kückelhaus CS; Kückelhaus SA; Muniz-Junqueira MI
Exp Parasitol; 2011 Mar; 127(3):658-64. PubMed ID: 21176775
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of in vivo leishmanicidal mechanisms by tempol: nitric oxide down-regulation and oxidant scavenging.
Linares E; Giorgio S; Augusto O
Free Radic Biol Med; 2008 Apr; 44(8):1668-76. PubMed ID: 18313408
[TBL] [Abstract][Full Text] [Related]
37. Canova, a Brazilian medical formulation, alters oxidative metabolism of mice macrophages.
de Oliveira CC; de Oliveira SM; Godoy LM; Gabardo J; Buchi Dde F
J Infect; 2006 Jun; 52(6):420-32. PubMed ID: 16386798
[TBL] [Abstract][Full Text] [Related]
38. Leishmania amazonensis: participation of regulatory T and B cells in the in vitro priming (PIV) of CBA/J spleen cells susceptible response.
Veras PS; Welby-Borges M; de Santana CD; Nihei J; Cardillo F; de Freitas LA
Exp Parasitol; 2006 Jul; 113(3):201-5. PubMed ID: 16516200
[TBL] [Abstract][Full Text] [Related]
39. Saliva of laboratory-reared Lutzomyia longipalpis exacerbates Leishmania (Leishmania) amazonensis infection more potently than saliva of wild-caught Lutzomyia longipalpis.
Laurenti MD; Silveira VM; Secundino NF; Corbett CE; Pimenta PP
Parasitol Int; 2009 Sep; 58(3):220-6. PubMed ID: 19454323
[TBL] [Abstract][Full Text] [Related]
40. Photodynamic therapy for American cutaneous leishmaniasis: the efficacy of methylene blue in hamsters experimentally infected with Leishmania (Leishmania) amazonensis.
Peloi LS; Biondo CE; Kimura E; Politi MJ; Lonardoni MV; Aristides SM; Dorea RC; Hioka N; Silveira TG
Exp Parasitol; 2011 Aug; 128(4):353-6. PubMed ID: 21575635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
